3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Multiple Myeloma
11
Neoplasms
8
Vomiting
6
Nausea
5
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Pain, Postoperative
2
Neoplasm, Residual
2
Lymphoma
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Wrist Fractures
1
Systemic Inflammatory Response Syndrome
1
Supratentorial Neoplasms
1
Radicular Cyst
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Mediastinal Neoplasms
1
Malnutrition
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
ferric carboxymaltose
2
streptococcal preparation 722
1
ferrous sulfate
1
Oxaliplatin
1
Leucovorin
1
Folfox protocol
1
Fluorouracil
1
Dexamethasone
1
Collagen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Postoperative Complications
×
Dexamethasone
×
Clear all
NCT03125941
2019-12-02
DEX-MAS
Rigshospitalet, Denmark
Phase 4
Completed
130 enrolled
20 charts